Opsens shines, winning two awards at the 7th annual stock company gala

Return to news

Opsens wins gold and ibr-qca awards

Opsens received one of the most prestigious awards of the evening, winning the Gold Award, which recognizes the company with the best stock market performance among firms listed on the TSX Venture Exchange. Opsens also won the Regional Performance Award, which is bestowed upon the company that performed best in the Quebec area. In his acceptance speech, Louis Laflamme, President and CEO of Opsens, said: “This award belongs to the employees and partners of the Company, who are committed to making Opsens a jewel of the Quebec economy.”

A positive and active start for 2014

In addition to the awards received yesterday, Opsens is proud of its recent accomplishments, which include:

  • The submission of Opsens’ FFR products for approval in Japan;
  • An $8.5 million equity financing with RBC Capital Markets, including Paradigm Capital Inc. and,
  • The grant of a US$6 million license to Abiomed, Inc. for Opsens’ miniature optical pressure sensor technology for applications in heart pump circulatory assist devices.

With these steps completed, Opsens is now poised to tackle other milestones for its FFR products, such as preparing to test its FFR products in humans, the final regulatory filings in the U.S. and Europe and, for oil and gas, expanding its base of recurring customers.